References
Catteau A, Harris WH, Xu CF, et al. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999;18:1957–65.
Rice JC, Ozcelik H, Maxeiner P. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis. 2000;21:1761–5.
Hedenfalk I, Duggan D, Chen Y. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539–48.
van’t Veer LJ, Dai H, Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–6.
Rice JC, Massey-Brown KS, Futscher BW. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 1998;17:1807–12.
Xu CF, Chambers JA, Solomon E. Complex regulation of the BRCA1 gene. J Biol Chem. 1997;272:20994–7.
Thakur S, Croce CM. Positive regulation of the BRCA1 promoter. J Biol Chem. 1999;274:8837–43.
Brabender J, Usadel H, Metzger R, et al. DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res. 2003;9:223–7.
Peters I, Rehmet K, Wilke N, et al. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Mol Cancer. 2007;16:49.
Snell C, Krypuy M, Wong EM, et al. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res. 2008;10:R12.
Breast Cancer Information Core Database 2007: http://research.nhgri.nih.gov/bic/
Malone CS, Miner MD, Doerr JR, et al. CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci USA. 2001;98:104040–10409.
Teng C, Gladwell W, Ralphiou I, et al. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals. 2004;17:317–23.
Chan QKY, Khoo US, Chan KYK, et al. Promoter methylation and differential expression of π-class glutathione s-transferase in endometrial carcinoma. J Mol Diagn. 2005;7:8–16.
Ramsahoye BH, Biniszkiewicz D, Lyko F, et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA. 2000;97:5237–42.
Grandjean V, Yaman R, Cuzin F. Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS ONE. 2007;2:e1136.
Acknowledgments
This study was supported by the Singapore National Medical Research Council (NMRC grant: R176-000-056-213).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ali, A.B., Iau, P.T.C. & Sng, JH. Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours. Med Oncol 28, 64–66 (2011). https://doi.org/10.1007/s12032-010-9438-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-010-9438-y